Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.992
+0.011 (1.16%)
At close: Dec 5, 2025, 4:00 PM EST
0.975
-0.017 (-1.71%)
After-hours: Dec 5, 2025, 6:58 PM EST
Oncolytics Biotech Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 16.02 | 13.34 | 16.08 | 11.49 | 13.32 | 12.51 | |
| Research & Development | 18.96 | 21.65 | 17.71 | 15.43 | 12.92 | 12.95 | |
| Operating Expenses | 34.98 | 34.98 | 33.79 | 26.92 | 26.24 | 25.46 | |
| Operating Income | -34.98 | -34.98 | -33.79 | -26.92 | -26.24 | -25.46 | |
| Interest & Investment Income | 0.48 | 1.2 | 1.33 | 0.53 | 0.1 | 0.12 | |
| Currency Exchange Gain (Loss) | 0.19 | 0.96 | -0.48 | 1.67 | -0.14 | -0.66 | |
| Other Non Operating Income (Expenses) | -1.1 | 1.24 | 5.29 | -0.02 | 0.02 | 3.49 | |
| EBT Excluding Unusual Items | -35.41 | -31.58 | -27.66 | -24.75 | -26.26 | -22.51 | |
| Pretax Income | -35.41 | -31.58 | -27.66 | -24.75 | -26.26 | -22.51 | |
| Income Tax Expense | -0.14 | 0.13 | 0.1 | 0.08 | 0.05 | - | |
| Net Income | -35.27 | -31.71 | -27.75 | -24.84 | -26.3 | -22.51 | |
| Net Income to Common | -35.27 | -31.71 | -27.75 | -24.84 | -26.3 | -22.51 | |
| Shares Outstanding (Basic) | 89 | 76 | 68 | 58 | 54 | 40 | |
| Shares Outstanding (Diluted) | 89 | 76 | 68 | 58 | 54 | 40 | |
| Shares Change (YoY) | 17.39% | 13.10% | 16.53% | 8.44% | 32.66% | 82.22% | |
| EPS (Basic) | -0.40 | -0.41 | -0.41 | -0.43 | -0.49 | -0.56 | |
| EPS (Diluted) | -0.40 | -0.41 | -0.41 | -0.43 | -0.49 | -0.56 | |
| Free Cash Flow | -26.48 | -27.21 | -28.46 | -23.41 | -22.72 | -22.1 | |
| Free Cash Flow Per Share | -0.30 | -0.36 | -0.42 | -0.40 | -0.42 | -0.55 | |
| EBITDA | -34.9 | -34.88 | -33.71 | -26.83 | -26.11 | -25.37 | |
| D&A For EBITDA | 0.09 | 0.1 | 0.08 | 0.09 | 0.13 | 0.09 | |
| EBIT | -34.98 | -34.98 | -33.79 | -26.92 | -26.24 | -25.46 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.